{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:12:45Z","timestamp":1792843965533,"version":"4.5.0"},"reference-count":23,"publisher":"Japan Endocrine Society","issue":"1","funder":[{"DOI":"10.13039\/100015851","name":"OPKO Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015851","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010793","name":"Pfizer Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010793","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1507\/endocrj.ej24-0625","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:07:47Z","timestamp":1761862067000},"page":"21-32","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy and safety of once-weekly somatrogon following up to 4 years of treatment in Japanese children with growth hormone deficiency: results from an open-label extension of a phase 3 study"],"prefix":"10.1507","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3429-3246","authenticated-orcid":false,"given":"Reiko","family":"Horikawa","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, National Center for Child Health and Development, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Tanaka Growth Clinic, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1288-9455","authenticated-orcid":false,"given":"Yukihiro","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Tokyo Metropolitan Children\u2019s Medical Center, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8945-4775","authenticated-orcid":false,"given":"Tohru","family":"Yorifuji","sequence":"additional","affiliation":[{"name":"2nd Department of Internal Medicine, Date Red Cross Hospital, Hokkaido, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ng","sequence":"additional","affiliation":[{"name":"WuXi Clinical, Austin, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron G.","family":"Rosenfeld","sequence":"additional","affiliation":[{"name":"Oregon Health &amp; Science University, Portland, OR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Hoshino","sequence":"additional","affiliation":[{"name":"Pfizer R&amp;D Japan, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5490-2606","authenticated-orcid":false,"given":"Akifumi","family":"Okayama","sequence":"additional","affiliation":[{"name":"Pfizer R&amp;D Japan, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3842-2578","authenticated-orcid":false,"given":"Nozomi","family":"Ebata","sequence":"additional","affiliation":[{"name":"Pfizer Japan, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5506-826X","authenticated-orcid":false,"given":"Masayoshi","family":"Hosoi","sequence":"additional","affiliation":[{"name":"Pfizer Japan, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Nakamuta","sequence":"additional","affiliation":[{"name":"Pfizer Japan, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Gomez","sequence":"additional","affiliation":[{"name":"Pfizer Pte Limited, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Pastrak","sequence":"additional","affiliation":[{"name":"OPKO Health, Inc., Miami, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orlando","family":"Castellanos","sequence":"additional","affiliation":[{"name":"OPKO Health, Inc., Miami, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Richmond E, Rogol AD (2020) Testing for growth hormone deficiency in children. Growth Horm IGF Res 50: 57\u201360.","DOI":"10.1016\/j.ghir.2019.12.002"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Collett-Solberg PF, Jorge AAL, Boguszewski MCS, Miller BS, Choong CSY, et al. (2019) Growth hormone therapy in children; research and practice\u2014a review. Growth Horm IGF Res 44: 20\u201332.","DOI":"10.1016\/j.ghir.2018.12.004"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Maghnie M, Ranke MB, Geffner ME, Vlachopapadopoulou E, Ib\u00e1\u00f1ez L, et al. (2022) Safety and efficacy of pediatric growth hormone therapy: results from the full KIGS cohort. J Clin Endocrinol Metab 107: 3287\u20133301.","DOI":"10.1210\/clinem\/dgac517"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Tanaka T (2022) Changes, limitations, and prospects of adult height in GH treatment for Japanese GHD patients. Clin Pediatr Endocrinol 31: 211\u2013224.","DOI":"10.1297\/cpe.2022-0034"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Laursen T (2004) Clinical pharmacological aspects of growth hormone administration. Growth Horm IGF Res 14: 16\u201344.","DOI":"10.1016\/j.ghir.2003.10.001"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Brod M, Alolga SL, Beck JF, Wilkinson L, H\u00f8jbjerre L, et al. (2017) Understanding burden of illness for child growth hormone deficiency. Qual Life Res 26: 1673\u20131686.","DOI":"10.1007\/s11136-017-1529-1"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Cutfield WS, Derraik JG, Gunn AJ, Reid K, Delany T, et al. (2011) Non-compliance with growth hormone treatment in children is common and impairs linear growth. PLoS One 6: e16223.","DOI":"10.1371\/journal.pone.0016223"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Hughes IP, Choong C, Rath S, Atkinson H, Cotterill A, et al. (2016) Early cessation and non-response are important and possibly related problems in growth hormone therapy: an OZGROW analysis. Growth Horm IGF Res 29: 63\u201370.","DOI":"10.1016\/j.ghir.2016.04.006"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 van Dommelen P, Koledova E, Wit JM (2018) Effect of adherence to growth hormone treatment on 0\u20132 year catch-up growth in children with growth hormone deficiency. PLoS One 13: e0206009.","DOI":"10.1371\/journal.pone.0206009"},{"key":"10","unstructured":"10 Christiansen JS, Backeljauw PF, Bidlingmaier M, Biller BM, Boguszewski MC, et al. (2016) Growth hormone research society perspective on the development of long-acting growth hormone preparations. Eur J Endocrinol 174: C1\u2013C8."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 McNamara M, Turner-Bowker DM, Westhead H, Yaworsky A, Palladino A, et al. (2020) Factors driving patient preferences for Growth Hormone Deficiency (GHD) injection regimen and injection device features: a discrete choice experiment. Patient Prefer Adherence 14: 781\u2013793.","DOI":"10.2147\/PPA.S239196"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Tanaka T, Sato T, Yuasa A, Akiyama T, Tawseef A (2021) Patient preferences for growth hormone treatment in Japanese children. Pediatr Int 63: 1185\u20131191.","DOI":"10.1111\/ped.14760"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Zelinska N, Iotova V, Skorodok J, Malievsky O, Peterkova V, et al. (2017) Long-acting C-terminal peptide-modified hGH (MOD-4023): results of a safety and dose-finding study in GHD children. J Clin Endocrinol Metab 102: 1578\u20131587.","DOI":"10.1210\/jc.2016-3547"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Fares F, Havron A, Fima E (2011) Designing a long acting erythropoietin by fusing three carboxyl-terminal peptides of human chorionic gonadotropin \u03b2 subunit to the N-terminal and C-terminal coding sequence. Int J Cell Biol 2011: 275063.","DOI":"10.1155\/2011\/275063"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Fares FA, Suganuma N, Nishimori K, LaPolt PS, Hsueh AJ, et al. (1992) Design of a long-acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin beta subunit to the follitropin beta subunit. Proc Natl Acad Sci U S A 89: 4304\u20134308.","DOI":"10.1073\/pnas.89.10.4304"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Deal CL, Steelman J, Vlachopapadopoulou E, Stawerska R, Silverman LA, et al. (2022) Efficacy and safety of weekly somatrogon <i>vs.<\/i> daily somatropin in children with growth hormone deficiency: a phase 3 study. J Clin Endocrinol Metab 107: e2717\u2013e2728.","DOI":"10.1210\/clinem\/dgac220"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Horikawa R, Tanaka T, Hasegawa Y, Yorifuji T, Ng D, et al. (2022) Efficacy and safety of once-weekly somatrogon compared with once-daily somatropin (Genotropin<sup>\u00ae<\/sup>) in Japanese children with pediatric growth hormone deficiency: results from a randomized phase 3 study. Horm Res Paediatr 95: 275\u2013285.","DOI":"10.1159\/000524600"},{"key":"18","unstructured":"18 Tanaka T, Yokoya S, Kato N, Ito Y, Tachibana K, et al. (2011) Basic approach to physique evaluation for Japanese children. J Jpn Ass Hum Auxo 17: 84\u201399 (In Japanese)."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Bozzola M, Meazza C (2010) Growth hormone deficiency: diagnosis and therapy in children. Expert Rev Endocrinol Metab 5: 273\u2013284.","DOI":"10.1586\/eem.09.69"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Isojima T, Hasegawa T, Yokoya S, Tanaka T (2017) The response to growth hormone treatment in prepubertal children with growth hormone deficiency in Japan: comparing three consecutive years of treatment data of The Foundation for Growth Science in Japan between the 1990s and 2000s. Endocr J 64: 851\u2013858.","DOI":"10.1507\/endocrj.EJ17-0063"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Straetemans S, Rooman R, De Schepper J (2021) Is a two-year growth response to growth hormone treatment a better predictor of poor adult height outcome than a first-year growth response in prepubertal children with growth hormone deficiency? Front Endocrinol (Lausanne) 12: 678094.","DOI":"10.3389\/fendo.2021.678094"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Fisher DM, Rosenfeld RG, Jaron-Mendelson M, Amitzi L, Koren R, et al. (2017) Pharmacokinetic and pharmacodynamic modeling of MOD-4023, a long-acting human growth hormone, in growth hormone deficiency children. Horm Res Paediatr 87: 324\u2013332.","DOI":"10.1159\/000470842"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Zadik Z, Zelinska N, Iotova V, Skorodok Y, Malievsky O, et al. (2023) An open-label extension of a phase 2 dose-finding study of once-weekly somatrogon <i>vs.<\/i> once-daily Genotropin in children with short stature due to growth hormone deficiency: results following 5 years of treatment. J Pediatr Endocrinol Metab 36: 261\u2013269.","DOI":"10.1515\/jpem-2022-0359"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/73\/1\/73_EJ24-0625\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T03:41:41Z","timestamp":1768016501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/73\/1\/73_EJ24-0625\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej24-0625","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"EJ24-0625"}}